ConductScience.org, home

Comparison · NCT03748420-c169ab45

Adherence Intervention vs Usual Care: Statin Medication Adherence

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Adherence Intervention vs Usual Care: Statin Medication Adherence. Trial comparisons, record NCT03748420-c169ab45. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03748420-c169ab45

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.5510.5210.581wilson
Risk in group 20.5090.4790.539wilson
Risk difference, group 1 minus group 20.0421-0.0005390.0846newcombe hybrid score
Risk ratio, group 1 over group 21.080.9991.17log
Odds ratio, group 1 over group 21.180.9981.41log
Number needed to treat, for one more participant with the outcome on Adherence Intervention than on Usual Care23.7from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: usual care.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Adherence Intervention
Patients in the medication adherence enhanced clinical decision support received the enhanced decision support intervention over a 6 month period. Patients were accrued over 6 months and followed for 12 months at which point they were assessed for improved medication adherence and clinical outcomes.
5861,063OG001
Group 2Usual Care
Patients in the usual care arm received the basic clinical decision support that is considered the standard of care at HealthPartners. Patients in this study group were accrued over 6 months and followed for 12 months at which point they were assessed for improved medication adherence and clinical outcomes.
5291,039OG000

Outcome

Type
PRIMARY
Title
Statin Medication Adherence
Description
Number of patients who achieve a proportion of days covered (PDC) greater than or equal to 80% for a statin medication if currently prescribed at 12 months following the index office visit date.
Time frame
12 months after an index visit
Population
Participants that had PDC less than 80% with moderate to high confidence.

Source ClinicalTrials.gov

Trial

Title
Medication Adherence Clinical Decision Support
NCT number
NCT03748420
Phases
NA
Conditions
Hyperlipidemia, Hypertension, Diabetes, Medication Nonadherence
Interventions
Adherence Intervention
Lead sponsor
HealthPartners Institute
Results first posted
2024-02-26

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT03748420-c169ab45